Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Repaglinide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Repaglinide 1mg tablets
0601023R0AAABAB
|
Repaglinide | Repaglinide | Endocrine System | 4,371 |
|
Repaglinide 2mg tablets
0601023R0AAACAC
|
Repaglinide | Repaglinide | Endocrine System | 3,832 |
|
Repaglinide 500microgram tablets
0601023R0AAAAAA
|
Repaglinide | Repaglinide | Endocrine System | 3,755 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.